Target type: biologicalprocess
The directed movement of inorganic diphosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:mah]
Inorganic diphosphate (PPi) transport is a crucial biological process involved in maintaining cellular energy balance and regulating various metabolic pathways. It involves the movement of PPi across cell membranes, often against its concentration gradient, requiring energy expenditure.
PPi is a by-product of numerous metabolic reactions, including the synthesis of ATP, nucleic acids, and proteins. Its accumulation can inhibit these processes, highlighting the importance of efficient PPi removal.
Transport mechanisms can be classified into two main categories:
1. **Active transport:** This energy-dependent process utilizes specialized membrane proteins called PPi transporters. These proteins bind PPi on one side of the membrane and, using energy derived from ATP hydrolysis or proton gradients, translocate it to the other side. This mechanism ensures unidirectional movement of PPi against its concentration gradient.
2. **Passive transport:** This process relies on the concentration gradient of PPi, allowing it to move from a region of high concentration to a region of low concentration. However, passive transport is not typically observed for PPi, as its intracellular concentration is usually low.
PPi transport plays significant roles in various cellular functions, including:
- **Energy metabolism:** PPi transport removes excess PPi, preventing its accumulation and ensuring optimal ATP production.
- **Signal transduction:** PPi can act as a signaling molecule, influencing enzyme activity and gene expression. Transport systems regulate its availability for signaling purposes.
- **Nucleic acid synthesis:** PPi is a substrate for the synthesis of DNA and RNA. Transport mechanisms ensure adequate PPi supply for these processes.
- **Protein synthesis:** PPi is released during protein synthesis, and its removal is essential for maintaining optimal translation rates.
Variations in PPi transport mechanisms exist across different organisms and cell types, reflecting their specific metabolic demands. The study of PPi transport is vital for understanding cellular energy homeostasis, metabolic regulation, and the development of potential therapeutic targets for various diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | An ectonucleotide pyrophosphatase/phosphodiesterase family member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P22413] | Homo sapiens (human) |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 | An ectonucleotide pyrophosphatase/phosphodiesterase family member 3 that is encoded in the genome of human. [PRO:WCB, UniProtKB:O14638] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha,beta-methyleneadenosine 5'-triphosphate | alpha,beta-methyleneadenosine 5'-triphosphate: do not confuse with beta,gamma-methylene ATP; RN given refers to parent cpd | nucleoside triphosphate analogue | |
adenosine 5'-methylenediphosphate | nucleoside diphosphate analogue | ||
3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate | 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate: purinergic receptors agonist; structure given in first source | purine ribonucleoside triphosphate | |
methylthio-adp | |||
Reactive blue 2 | anthraquinone | ||
2-methylthio-atp | 2-methylthio-ATP: purinergic receptors agonist; relaxes mammalian gut preparations; structure given in first source | ||
adenosine 5'-diphosphate 2',3'-dialdehyde | |||
arl-67156 | 6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP: an inhibitor of ecto-ATPase |